Unique ID issued by UMIN | UMIN000027772 |
---|---|
Receipt number | R000031828 |
Scientific Title | The efficacy of a microwave device for treating axillary hyperhidrosis: Split-patient (1Pass vs 2Pass) comparative study |
Date of disclosure of the study information | 2017/06/16 |
Last modified on | 2024/06/24 17:19:37 |
The efficacy of a microwave device for treating axillary hyperhidrosis: Split-patient (1Pass vs 2Pass) comparative study
The efficacy of a microwave device for treating axillary hyperhidrosis
The efficacy of a microwave device for treating axillary hyperhidrosis: Split-patient (1Pass vs 2Pass) comparative study
The efficacy of a microwave device for treating axillary hyperhidrosis
Japan |
primary axillary hyperhidrosis
Dermatology |
Others
NO
Evidence for an effective and safe treatment protocol in this treatment
Efficacy
Comparison of sweating amount by gravimetric method: amount of perspiration at 24 weeks after treatment between 1 or 2 pass groups
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Active
2
Treatment
Device,equipment |
Once per treatment
Twice per treatment
20 | years-old | <= |
65 | years-old | >= |
Male and Female
(1) over 20 years old
(2) hyperhidrosis in both axillary bilateral symmetry
Axillary hyperhidrosis is the case where locally excessive perspiration is observed for more than 6 months without obvious cause and more than 2 of the following 6 symptoms apply
1)appear to be 25 years or younger
2)Sweating is seen in symmetry
3)Sweating stops while sleeping
4)episodes of multiple perspiration at least once in a week
5)have a family history
6)to interfere with everyday life by them
(3) perspiration from each axilla is 50 mg / 5 minutes or more
(4) HDSS 3 or 4
(1) Secondary hyperhidrosis
(2) Frey syndrome
(3) Topical application of aluminum chloride within 4 weeks of consent acquisition
(4) Local injection of botulinum toxin type A was conducted within one year of consent acquisition
(5) Oral intake of anticholinergic drug within 2 weeks of acquiring consent
(6) I underwent surgery on the axillary part
(7) Serious underlying disease (history of xylocaine shock)
(8) Diseases requiring systemic administration such as steroids
(9) Systemic diseases such as collagen diseases that have impaired wound healing
(10) any type of pacemaker implantation
32
1st name | Tsuyoshi |
Middle name | |
Last name | Namiki |
Tokyo Medical and Dental University hospital
Dermatology
113-8519
1-5-45 Yushima, Bunkyo-ku, Tokyo,Japan
03-5803-5286
tnamderm@tmd.ac.jp
1st name | Takichi |
Middle name | |
Last name | Munetsugu |
Tokyo Medical and Dental University Hospital
Dermatology
113-8519
1-5-45 Yushima, Bunkyo-ku, Tokyo,Japan
03-5803-5286
mtakderm@tmd.ac.jp
Tokyo Medical and Dental University Hospital
JMEC Co.,LTD
Other
Tokyo Medical and Dental University
1-5-45 Yushima, Bunkyo-ku, Tokyo,Japan
03-5803-5286
tiken.crc@tmd.ac.jp
NO
2017 | Year | 06 | Month | 16 | Day |
Unpublished
32
Completed
2017 | Year | 08 | Month | 10 | Day |
2017 | Year | 10 | Month | 20 | Day |
2017 | Year | 12 | Month | 01 | Day |
2021 | Year | 09 | Month | 30 | Day |
2017 | Year | 06 | Month | 15 | Day |
2024 | Year | 06 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031828